Why is Alfressa planning to consolidate ArkMS as a subsidiary?

Due to the increased importance of Total Supply Chain Services (TSCS) in pharmaceutical development support (CRO business), Alfressa is strengthening its management structure to provide services as a unified group.

TSCS is a service provided by the Alfressa Group that supports the entire process from the introduction and development of pharmaceuticals to manufacturing, logistics, sales, and post-market surveillance (PMS).

When will the consolidation begin?

It is scheduled to be included in the consolidated scope from the first quarter of the fiscal year ending March 2027 (2026 fiscal year).

AI News NQ Analysis

Notice Regarding Changes in Subsidiary (Conversion of a Non-consolidated Subsidiary into a Consolidated Subsidiary) and Management Structure

NQ Score 42/100

N1 Content Completeness 4

AI Summary (NQ-processed)

Alfresa Holdings announced that it will include its non-consolidated subsidiary ArkMS Co., Ltd., which operates a CRO business, into its scope of consolidation starting from the first quarter of the fiscal year ending March 2027. This move is intended to strengthen the group's 'Total Supply Chain Service' (TSCS) by enhancing its pharmaceutical development support capabilities.

AI Analysis

Frequently Asked Questions

Q: Why is Alfressa planning to consolidate ArkMS as a subsidiary?: A: Due to the increased importance of Total Supply Chain Services (TSCS) in pharmaceutical development support (CRO business), Alfressa is strengthening its management structure to provide services as a unified group.
Q: What is TSCS?: A: TSCS is a service provided by the Alfressa Group that supports the entire process from the introduction and development of pharmaceuticals to manufacturing, logistics, sales, and post-market surveillance (PMS).
Q: When will the consolidation begin?: A: It is scheduled to be included in the consolidated scope from the first quarter of the fiscal year ending March 2027 (2026 fiscal year).